LeMaitre Vascular, Inc.
LMAT
$81.91
$3.093.92%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 55.72M | 54.82M | 55.85M | 53.48M | 48.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 55.72M | 54.82M | 55.85M | 53.48M | 48.88M |
| Cost of Revenue | 17.13M | 17.64M | 17.38M | 16.81M | 15.62M |
| Gross Profit | 38.59M | 37.18M | 38.47M | 36.67M | 33.27M |
| SG&A Expenses | 22.12M | 20.37M | 19.80M | 20.70M | 18.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.86M | 41.67M | 41.47M | 41.60M | 38.68M |
| Operating Income | 12.85M | 13.15M | 14.38M | 11.87M | 10.21M |
| Income Before Tax | 14.02M | 14.55M | 15.51M | 12.80M | 11.31M |
| Income Tax Expenses | 2.84M | 3.41M | 3.68M | 2.91M | 2.85M |
| Earnings from Continuing Operations | 11.18M | 11.14M | 11.83M | 9.89M | 8.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.18M | 11.14M | 11.83M | 9.89M | 8.47M |
| EBIT | 12.85M | 13.15M | 14.38M | 11.87M | 10.21M |
| EBITDA | 15.33M | 15.57M | 16.76M | 14.26M | 12.65M |
| EPS Basic | 0.50 | 0.50 | 0.53 | 0.44 | 0.38 |
| Normalized Basic EPS | 0.39 | 0.40 | 0.43 | 0.36 | 0.32 |
| EPS Diluted | 0.48 | 0.49 | 0.52 | 0.44 | 0.37 |
| Normalized Diluted EPS | 0.38 | 0.40 | 0.43 | 0.35 | 0.31 |
| Average Basic Shares Outstanding | 22.51M | 22.48M | 22.46M | 22.37M | 22.28M |
| Average Diluted Shares Outstanding | 22.90M | 22.84M | 22.73M | 22.57M | 22.46M |
| Dividend Per Share | 0.16 | 0.16 | 0.16 | 0.16 | 0.14 |
| Payout Ratio | 32.19% | 32.28% | 30.38% | 36.30% | 36.81% |
